Russian specialists have developed a tool for the treatment of eye diseases. Often this pathology leads to a sharp deterioration in the quality of life and even blindness. The first stage tests on laboratory animals have shown excellent results in some cases medication was restored vision even with blindness.
A drug called SkQ1 was approved by the American Fund for the FDA to conduct clinical trials on human volunteers. It is quite possible that the new development of the Russian scientists will become the "gold standard" in the treatment of eye diseases and vision recovery.
Russian experts also plan to conduct trials in humans. First of all, the drug will be tested on volunteers without eye diseases, then the tool will try in different pathologies of the visual organ.
In the future, scientists from Russia are going to develop means acting in a complex: not only eyes, but also on the entire body.